Shinichi Koizumi
Directeur/Bestuurslid bij TSUBOTA LABORATORY INCORPORATED
Profiel
Shinichi Koizumi is currently the Director, Vice President & CSO at AskAt, Inc. He is also an Independent Outside Director at Tsubota Laboratory, Inc. In the past, he served as the Executive Vice President at RaQualia Pharma, Inc. Dr. Koizumi holds a doctorate degree from Tokyo Institute of Technology, which he obtained in 1986.
Actieve functies van Shinichi Koizumi
| Bedrijven | Functie | Begin |
|---|---|---|
| TSUBOTA LABORATORY INCORPORATED | Directeur/Bestuurslid | 01-06-2020 |
AskAt, Inc.
 AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 |
Eerdere bekende functies van Shinichi Koizumi
| Bedrijven | Functie | Einde |
|---|---|---|
| RAQUALIA PHARMA INC. | Hoofd Techniek/Wetenschap/O&O | 29-11-2012 |
Opleiding van Shinichi Koizumi
| Tokyo Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| RAQUALIA PHARMA INC. | Health Technology |
| TSUBOTA LABORATORY INCORPORATED | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
AskAt, Inc.
AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015. | Health Technology |
